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We report the development and initial experimental validation of
a computational design procedure aimed at generating enzyme-
like protein catalysts called ‘‘protozymes.’’ Our design approach
utilizes a ‘‘compute and build’’ strategy that is based on the
physicalchemical principles governing protein stability and cata-
lytic mechanism. By using the catalytically inert 108-residue Esch-
erichia coli thioredoxin as a scaffold, the histidine-mediated nu-
cleophilic hydrolysis of p-nitrophenyl acetate as a model reaction,
and the ORBIT protein design software to compute sequences, an
active site scan identified two promising catalytic positions and
surrounding active-site mutations required for substrate binding.
Experimentally, both candidate protozymes demonstrated cata-
lytic activity significantly above background. One of the proteins,
PZD2, displayed ‘‘burst’’ phase kinetics at high substrate concen-
trations, consistent with the formation of a stable enzyme inter-
mediate. The kinetic parameters of PZD2 are comparable to early
catalytic Abs. But, unlike catalytic Ab design, our design procedure
is independent of fold, suggesting a possible mechanism for
examining the relationships between protein fold and the evolv-
ability of protein function.
A prominent goal of protein design is the generation ofproteins with novel functions, including the catalytic rate
enhancement of chemical reactions. The ability to design an
enzyme to perform a given chemical reaction has considerable
practical application for industry and medicine, particularly for
the synthesis of pharmaceuticals (1). Significant progress has
been made at enhancing the catalytic properties of existing
enzymes through directed evolution (2). In contrast, the design
of proteins with novel catalytic properties has met with relatively
limited success (3–5). We present a general computational
approach for the design of enzyme-like proteins with novel
catalytic activities.
The use of transition-state analogs as haptens to elicit catalytic
Abs has been the most successful technique to date for gener-
ating novel protein catalysts (6). Natural enzymes combine
transition-state stabilization with precisely oriented catalytic
side chains. Although a reactive hapten has been used in the
generation of an Ab with a powerful nucleophile at the active site
(7), current catalytic Ab technology does not efficiently select for
both catalytic side chains and tight noncovalent affinity in the
same molecule. The relationship between the general backbone
fold of an enzyme and its catalytic properties is not well
understood. This observation is particularly relevant to catalytic
Abs that are currently constrained to the Ab fold and which have
yet to show catalytic activity on par with natural enzymes.
Rational design efforts have recently succeeded at altering the
catalytic reactions of two different enzymes (8, 9). Cyclophilin,
a cis-trans isomerase of X-Pro peptide bonds, was engineered
into an endopeptidase by grafting a triad of catalytic residues
commonly found in serine proteases at the binding cleft (8). In
a more complicated design effort, Fersht and coworkers (9) were
able to convert indoleglycerol-phosphate synthase into phospho-
ribosylanthranilate isomerase. The naturally occurring versions
of these enzymes share a similar fold and catalyze consecutive
reactions in the tryptophan biosynthetic pathway with the prod-
uct of the isomerase being the substrate for the synthase. On the
basis of a comparison of the crystal structures of both natural
enzymes, loops were altered in the synthase to resemble the
target isomerase, followed by directed evolution. These two
successful design efforts both used starting proteins with sub-
stantial substrate affinity and altered existing active-site residues
to catalyze new reactions.
Compared with altering substrate specificity or catalytic mech-
anism, one of the most significant challenges of enzyme design
utilizes a starting protein scaffold devoid of substrate binding
and catalytic activity and introduces residues that convert the
scaffold into an enzyme (10). Computational techniques have
been used to design novel metal binding sites into proteins
(11–13). By leaving one of the primary coordination spheres of
the metal unligated by the protein, nascent metalloenzymes
with a variety of oxygen redox chemistries have been generated
(14, 15). The general design of metalloenzymes to react specif-
ically with more complicated organic molecules has not been
demonstrated.
Numerous studies of natural proteins have revealed the basic
principles of enzymatic catalysis, including proximity and orien-
tation of substrate molecules, transition-state stabilization, acid-
base catalysis, and covalent catalysis (16). The continued im-
provement in computer speed combined with the development
and improvement of computational protein design algorithms
(17–19) and force fields (20) makes this an opportune time to
apply our understanding of enzyme mechanism to the rational,
computational design of enzymes with novel functions. We
model a high-energy state along a specified reaction pathway
including the interaction of at least one catalytic residue with the
high-energy state. The computational techniques described be-
low, which have been incorporated into the ORBIT (Optimization
of Rotamers By Iterative Techniques) protein design software
(17), identify catalytic sites within a protein structure as well as
mutations necessary to accommodate substrate binding (that is,
to build the active site).
The histidine-mediated nucleophilic hydrolysis of p-
nitrophenyl acetate (PNPA) into p-nitrophenol (PNP) and ac-
etate (Fig. 1A) was selected as the target reaction. This reaction
has a moderate activation barrier in pH neutral aqueous solution
and is similar to the ester and carbonate hydrolysis reactions
studied by the first catalytic Abs (21, 22). Nucleophile-catalyzed
hydrolysis is commonly achieved by using a catalytic serine or
cysteine in natural proteases. Histidine is often used as a general
acid or base, but occasionally histidine acts as a nucleophile in
phosphate transfer reactions. For nucleophilic catalysis to be
effective, the acylated enzyme intermediate must be unstable
relative to substrate in buffer to increase the rate of product
formation over the uncatalyzed buffer rate. An acyl-histidine
intermediate would be less stable than either an acyl-serine or an
acyl-cysteine intermediate. Therefore, we modeled histidine as
the nucleophile in our design.
Abbreviations: PNP, p-nitrophenyl; PNPA, PNP acetate; PZD, protozyme design.
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Materials and Methods
Molecular Modeling. For the histidine-PNPA high-energy state
rotamers, a backbone-independent rotamer library was gener-
ated that included nucleophilic attack by both the N and N
atoms of histidine and attack on both enantiotopic faces of
PNPA. The 1 and 2 dihedral angles were based on histidine
dihedral angles in a survey of protein structures (23) and were
expanded by 1 SD from the reported values. Dihedral angles
for 3 (30,90, and150°), 4 (60 and 180°), and 5 (90°)
were based on canonical values for the relevant central atom
hybridizations as described in the DREIDING force field (24).
Bond lengths and angles as well as additional dihedral angles
were optimized by using the DREIDING force field (24). All
other side chains were modeled by using a backbone-dependent
rotamer library (23) that was expanded about 1 and 2 dihedral
angles for aromatic residues, expanded about 1 dihedral angle
for aliphatic residues, and unexpanded for polar residues as
described (25).
The calculations used an energy function based on the
DREIDING force field (24). A Lennard–Jones 12–6 potential
with van der Waals radii scaled by 0.9 was applied to all side
chain–backbone and side chain–side chain interactions as de-
scribed (26). An explicit hydrogen bond potential was applied to
all groups that contained hydrogen bond donors andor accep-
tors (including the high-energy state complex). The 12–10
hydrogen bond potential used a well depth of 8.0 kcalmol, an
equilibrium donoracceptor distance of 2.8 Å, and a hybridiza-
tion-dependent angle term as described (27). Electrostatic en-
ergies were computed by using a distance-dependent dielectric
constant of 40r with partial atomic charges as described (27).
Partial atomic charges for the high-energy state rotamers were
generated by using the same bond polarization scheme used for
the other amino acids and included a net 1 charge on the
histidine moiety and a net 1 charge on the high-energy state
substrate (Table 2, which is published as supporting information
on the PNAS web site, www.pnas.org). A surface area-based
atomic solvation potential was selectively applied to the high-
energy state rotamers to favor interaction of the substrate with
the protein (i.e., only surface area burial of atoms on the
high-energy state rotamers was considered). This selective ap-
plication of the solvation potential, which differs from our
previous work, was required to reduce the tendency of gener-
ating predominately wild-type amino acid sequence solutions.
Surface areas for the solvation potential were calculated by using
the Connolly algorithm (28) and the definition of solvent-
accessible surface area by Lee and Richards (29) with unscaled
atomic radii and an add-on radius of 1.4 Å. A hydrophobic burial
benefit of 48 calmolÅ2 and a hydrophobic exposure penalty of
76.8 calmolÅ2 were used with the two-body decomposition
method of Street and Mayo (30). The solvation potential was not
applied to polar atoms.
The hydrophobic solvent-accessible surface area of substrate
atoms was used to evaluate recognition. For this assessment,
solvent-accessible surface area was computed by using the
Connolly algorithm (28) and the Lee and Richards definition of
solvent-accessible surface area (29) with an add-on radius of 1.4
Å. The solvent-accessible surface area of the substrate was
determined by using all atoms in the folded structure as well as
by using an unfolded reference that included only the high-
energy state rotamer and the local backbone. Active-site designs
were ranked by the fraction-accessible surface area defined as
the ratio of hydrophobic-accessible surface area in the folded
structure and the hydrophobic-accessible surface area in the
unfolded reference. Computed designs with zero total solvent-
accessible surface area for the substrate atoms were considered
inaccessible to substrate and were eliminated from further
consideration.
Experimental Validation. The background mutation D26I was
included in both protozyme design (PZD) 1 and 2. D26I was
predicted by ORBIT in an independent calculation and results in
increased thermodynamic stability similar to the previously
reported D26A protein (31). Position 26 is distant in space to the
designed active sites in both PZD1 and PZD2.
The genes for PZD1 and PZD2 were constructed by site-
directed mutagenesis, using the wild-type thioredoxin gene
(Invitrogen) cloned into PET-11A. Protein expression was in-
duced with 0.5 mM IPTG from BL21(DE3) cells grown to
mid-log phase. Cells were lysed by sonication and pelleted twice
at 20,000 g for 30 min. The soluble fraction was brought to 60%
acetonitrile, pelleted, and rotary-evaporated to half volume. For
initial studies, purification was accomplished by reversed-phase
HPLC. For subsequent studies with PZD2, all protein samples
were additionally purified by ion exchange and size exclusion
chromatography to a purity of 99% as judged by silver-stained
PAGE.
PZD2 was dialyzed extensively against 10 mM sodium phos-
phate buffer at pH 6.95. Kinetic experiments at 22°C were
started by the addition of substrate dissolved in acetonitrile to
buffer solution with and without PZD2 (final protein concen-
tration of 4 M). Protein concentration was determined by UV
absorbance in 6 M guanidinium hydrochloride assuming an
extinction coefficient of 12,400 M1cm1 at 280 nm. Product
concentration was determined by the change in absorbance at
400.5 nm assuming an extinction coefficient for deprotonated
PNP of 19,700 M1cm1. Final acetonitrile concentration was
1% for all experiments. The steady-state rate of hydrolysis by
PZD2 was corrected for the buffer rate. Burst-phase hydrolysis
assays were performed at a substrate concentration of 1.6 mM.
Protein concentration was 4 M, with the exception of wild-type
thioredoxin. Wild-type thioredoxin was assayed at 50 M to
Fig. 1. (A) Nucleophile-mediated catalysis of PNPA hydrolysis. (B) High-
energy state structure used in the computational active site scan. Labeled
dihedral angles were varied to generate the set of high-energy state rotamers
used in the design calculations.
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improve signal to noise and extrapolated to a protein concen-
tration of 4 M. The dead time for this experiment was30 sec.
The 42 mass unit species detected in the trapping experi-
ment is a result of replacement of a hydrogen (1) with an acetyl
group (43). PZD2 (100 M ) in 10 mM Tris at pH 7.0 was
reacted with 1.6 mM PNPA to steady-state conditions, and a
mass spectrum was acquired. The same protein solution without
PNPA was used as a control. Burst-phase kinetics in this buffer
system yielded essentially identical results as in phosphate buffer.
Results and Discussion
An important step in the design of a protein catalyst is locating
the substrate relative to the protein scaffold. We took advantage
of the observation that the vast majority of natural enzymes
contain one or more side chains in highly specific geometric
relation to substrate. In the case of PNPA hydrolysis catalyzed
by histidine, the histidine side chain should be positioned with a
nitrogen atom approaching the carbonyl carbon adjacent to the
scissile bond. In a procedure reminiscent of transition-state
analog synthesis for catalytic Ab design, we modeled a high-
energy state of histidine-catalyzed PNPA hydrolysis as a series of
side chain rotamers (Fig. 1B). The rotamer model focuses the
subsequent search on the relevant phase space where a catalytic
side chain can be positioned to interact with substrate atoms.
Modeling a high-energy state and optimizing the surrounding
protein sequence for binding to the high-energy state may lead
to a reduction in activation energy for the reaction and catalytic
rate enhancement (32). Substrate affinity is explicitly included in
the design because chemical similarity exists between the high-
energy state and the substrate.
The well studied protein Escherichia coli thioredoxin (33) was
selected as a scaffold because of its favorable expression prop-
erties, thermodynamic stability (34), and successful history in
computational design (15). Naturally occurring thioredoxin can
supply the reducing power for ribonucleotide reductase by way
of its disulfide bond, but is essentially catalytically inert with
respect to PNPA binding and hydrolysis. The high thermody-
namic stability of thioredoxin suggests that it can tolerate
destabilizing mutations that are required to build an active site
(35). An active site scan was performed to identify favorable
positions for the catalytic histidine as well as mutations necessary
for substrate recognition and binding. In separate calculations
using the ORBIT computational protein design programs, each
position in the protein structure of thioredoxin was modeled by
using the set of high-energy state rotamers (Fig. 1B). All other
positions in the protein were allowed to choose (with proper
consideration for rotamer flexibility) between their wild-type
identity and alanine to accommodate the substrate and to build
the active site. After computing the optimal solution by using
algorithms based on the Dead-End Elimination theorem (36,
37), positions that changed to alanine can be subsequently
allowed to change identity to other amino acids to form better
interactions with the high-energy state rotamer. The results
reported below are based on the first stage calculation that allows
only mutation to alanine. The initial limited combinatorial
complexity approach provides for tractable calculations and is
expected to generate enzyme-like proteins that we call pro-
tozymes. As computer power and computational methods be-
come more sophisticated, the need for a two-stage calculation
will diminish. All 94 nonglycine nonproline positions, a combi-
natorial complexity of 1026 amino acid sequences that corre-
sponded to 10101 rotamer sequences, were scanned in approxi-
mately 2 days on 14 195 MHz R10000 processors (Silicon
Graphics, Mountain View, CA) running in parallel. Hydropho-
bic solvent-accessible surface area of the substrate atoms in the
computed high-energy state was used as a measure of substrate
recognition to rank designs (resulting from the limited combi-
natorial complexity calculations) (Table 1). In addition, the
simple requirement that the total solvent-accessible surface area
of the substrate atoms be greater than zero was used to eliminate
designs where the active site would not be accessible.
Fig. 2. Molecular surfaces (43) focusing on the active site of PZD2 with substrate atoms in green (A) and the corresponding region in the x-ray crystal structure
(38) of the wild-type scaffold (B and C). An active-site cleft is present in the design of PZD2 that is largely filled in the wild-type structure. Wild-type residues that
were mutated to create the active site are shown in C (F12, L17, and Y70). In the design of PZD2, all side chains were allowed to change geometry, resulting in
a slightly different surface compared with that of the wild-type protein.
Table 1. Top 10 designs from active site scan
Design
Catalytic His
position
Fraction hydrophobic
exposure Active site mutations
PZD1 12 0.11 F12H Y70A
PZD2 17 0.15 F12A L17H Y70A
PZD3 86 0.29 V86H I38A L42A L99A
PZD4 72 0.34 I72H L79A
PZD5 66 0.34 T66H F12A Y70A
PZD6 6 0.36 None
PZD7 39 0.37 A39H K57A
PZD8 91 0.39 V91H T77A
PZD9 49 0.39 Y49H K52A
PZD10 77 0.43 T77H L79A T89A
Ranked based on hydrophobic surface area burial of substrate atoms in the
high-energy state complex. The top two designs, PZD1 and PZD2, were ex-
perimentally tested for catalytic activity.
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The top two sequences from the limited combinatorial com-
plexity active site scan were selected for experimental analysis.
PZD1 contains two mutations (F12H and Y70A) required to
introduce the catalytic histidine and to build the active site,
whereas PZD2 contains three mutations (F12A, L17H, and
Y70A). Experimentally, both proteins demonstrated catalytic
hydrolysis of PNPA at a rate significantly above background.
Based on preliminary kinetic experiments at high substrate
concentration, PZD2 was approximately twice as effective a
catalyst as PZD1 and was selected for further analysis. The
designed structure of PZD2 computed by ORBIT shows the
substrate atoms in a cleft (Fig. 2A). This cleft is not present in
the wild-type thioredoxin x-ray structure (ref. 38; Fig. 2B),
indicating that the space-creating mutations (F12A and Y70A)
are necessary to create the putative substrate-binding site
(Fig. 2C).
The rate of PNPA hydrolysis by PZD2 at 22°C in 10 mM
sodium phosphate buffer at pH 6.95 was experimentally deter-
mined over a range of substrate concentrations with standard
Briggs–Haldane steady-state treatment (Fig. 3). The reaction
velocity of PZD2 demonstrated saturation kinetics with respect
to increasing substrate concentration (Fig. 4), indicating that the
molecule is acting as an enzyme-like protein with both substrate
affinity and catalytic rate enhancement. Hofstee analysis of the
data gives a Km of 170  20 M, kcat of 4.6  0.2  104 sec1,
and kcatkuncat of 180 where kuncat (2.5  106 sec1) is the rate
of hydrolysis under the same conditions. The kinetics of PZD2
are comparable to those of the first catalytic Abs: Km of 208 M
and kcatkuncat of 770 for MOPC167 (21) and Km of 1.9 M and
kcatkuncat of 960 for 6D4 (22).
De novo-designed peptides have recently been designed which
catalyze PNPA hydrolysis by a second-order mechanism (i.e.,
without substrate saturation). The second-order rates for these
peptides were determined under different conditions than those
used here, making direct comparisons difficult. At pH 5.1, rates
of 0.29 M1sec1 and 0.056 M1sec1 have been reported (39,
40). Extrapolation based on the pH rate profiles (39) reported
for the hydrolysis of similarly activated esters suggests rates of
0.7 and 0.2 M1sec1 for PNPA hydrolysis at pH 7, respec-
tively. The second-order rate of hydrolysis by 4-methyl imidazole
(determined under the conditions used in the analysis of PZD2)
is 0.11 M1sec1. Computing a second-order rate of hydrolysis
for PZD2 as kcatKm gives 2.7 M1sec1, which is a factor of 25
better than catalysis by 4-methyl imidazole and about an order
of magnitude better than the peptide systems. It is extremely
important to note, however, that the lack of substrate saturation
in the second-order systems complicates this analysis because
substrate affinity was determined for PZD2. Substrate affinity is
central to enzyme catalysis and clearly will be important in the
design of protein-based catalysts for more complicated reactions.
At high substrate concentrations, an initial ‘‘burst’’ phase is a
common feature of natural enzymes and is a consequence of a
kinetic bottleneck on the reaction pathway. PZD2 displays
burst-phase kinetics at high substrate concentration (Fig. 5)
consistent with the formation of an enzyme intermediate. The
observed burst-phase kinetics could also be a result of slow
product release; however, this is unlikely given the kinetic
parameters of PZD2. Based on the burst-phase data, we estimate
Ks  1 mM, k2  3  103 sec1, and k3  8  104 sec1.
Analysis of the magnitude of the burst indicates that 30% of
PZD2 is in an active state. Using the burst magnitude as a metric
of the enzyme concentration indicates a kcat of 1.5  0.1  103
sec1, approximately 3 times larger than the kinetic analysis with
enzyme concentrations determined from protein UV
absorbance.
Wild-type thioredoxin is essentially inactive, but does show
weak second-order PNPA hydrolysis consistent with its single
surface-exposed histidine at position 6. Mutation of the designed
catalytic histidine to alanine in PZD2 (H17A) results in a protein
with catalytic activity similar to wild-type thioredoxin, indicating
that the designed catalytic histidine at position 17 is necessary for
the enzyme-like activity in PZD2 (Fig. 5). Mutation of the two
other active site residues in PZD2 back to their wild-type
identities (A12F and A70Y) also results in a protein with activity
Fig. 3. Kinetic model used to analyze the activity of PZD2.
Fig. 4. Velocity vs. substrate concentration for the hydrolysis of PNPA by
PZD2.
Fig. 5. Buffer-corrected hydrolysis of PNPA by PZD2 (F), PZD2 H17A (),
wild-type thioredoxin (Œ), and wild-type L17HD26I (). Data are shown for
high substrate concentration and equivalent low protein concentration.
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similar to wild type. Additionally, at pH 5.7 the activity of PZD2
is almost entirely eliminated, consistent with protonation of the
catalytic histidine (data not shown). The kinetic and mutational
evidence strongly indicate that PZD2 is working as designed with
H17 acting as a catalytic nucleophile, and the space-creating
mutations (F12A and Y70A) forming a binding site for substrate.
According to its design, reaction of PZD2 with PNPA should
yield an acyl-histidine enzyme intermediate, increasing the
population of a 42-mass unit species compared with free
protein. Mass spectrometry of PZD2 clearly indicates increased
population of an acylated species on reaction with PNPA (Fig.
6 A and B). Acylation due to reaction with PNPA is essentially
absent for the H17A mutant of PZD2 (Fig. 6 C and D), indicating
that acylation depends on H17. From the data it is not possible
to distinguish between direct acylation of H17 or H17-mediated
(acidbase or acyl transfer) acylation of a different residue.
Naturally occurring enzymes are frequently inhibited in a
competitive manner by inert compounds resembling the sub-
strate molecule. With this in mind, we assayed the inhibitory
effects of p-nitrophenyl glycerol (PNPG) a highly soluble com-
pound with structural similarity to PNPA. A double reciprocal
analysis of PZD2 catalyzed PNPA hydrolysis in the presence and
absence of inhibitor shows the hallmark features of competitive
inhibition (Fig. 7) implying that PNPG is able to bind in the
active site and block PNPA binding. A Dixon analysis, varying
PNPG concentration at a fixed substrate concentration of 200
M yielded a Ki of 20 mM. The decreased binding affinity of
PNPG relative to PNPA may be due to burial of polar hydroxyl
groups against hydrophobic regions in the active site or differ-
ences in the steric requirements for PNPG and PNPA. No
inhibition was detected with PNP phosphate at concentrations
up to 20 mM, suggesting that PZD2 binds preferentially to
uncharged nitrophenyl molecules.
To further test the substrate specificity of PZD2, we assayed
its kinetics with PNP propionate (PNPP), which has an addi-
tional methylene group compared with PNPA. Hofstee analysis
indicates within error an identical kcatkuncat and a Km of 110 
20 M for PNPP, compared with 170  20 M for PNPA.
Inspection of the designed structure of PZD2 with bound PNPA
shows that space exists to accommodate the additional methyl-
ene of PNPP. Both favorable van der Waals interactions and
hydrophobic burial afforded by the relatively open active site
likely explain the slightly increased affinity of PZD2 for PNPP
compared with PNPA.
Conclusions
The computational design method presented here successfully
identified enzyme-like active sites within a protein scaffold
essentially devoid of relevant catalytic activity. Although the
reaction catalyzed (PNPA hydrolysis) and the level of activity of
PZD2 are likely to be insufficient for practical applications, clear
paths for improvement exist including further computational
optimization and experimentally directed evolution. Computa-
tional optimization of the identity of residues proximal in space
to the high-energy state complex could result in improved shape
and charge complementarity with the high-energy state, improv-
ing both substrate affinity and catalytic rate enhancement.
Directed evolution, combining mutagenesis and recombination
with screening andor selection, has been an effective method
for increasing catalytic activity. The use of computational mod-
eling to focus directed evolution experiments promises to in-
Fig. 6. Trapping of an acylated intermediate by mass spectrometry. (A) PZD2,
(B) PZD2 reacted with substrate, (C) PZD2 H17A, and (D) PZD2 H17A reacted
with substrate. A large increase in the population of a 42 species occurs on
reaction of PZD2 with substrate, indicating the buildup of an acyl-enzyme
intermediate. This 42 species is dramatically reduced for PZD2 H17A where
the designed catalytic histidine was mutated to alanine. A small increase in the
population of a 42 species is detected in PZD2 H17A on reaction with
substrate and is likely the result of acylation at the single surface-exposed
histidine at position 6. Consistent with this analysis, a small increase in the
population of a double acetylated 84 product is detected on reaction of
PZD2 with substrate. A copper matrix adduct (63) is present (38) in all spectra
and in combination with free and acylated protein results in multiple peaks.
Fig. 7. Lineweaver–Burk analysis of PZD2-catalyzed PNPA hydrolysis in the
presence () and absence (F) of 10 mM PNPG.
14278  www.pnas.orgcgidoi10.1073pnas.251555398 Bolon and Mayo
crease the effectiveness of directed evolution methods (41). For
the creation and optimization of novel protein catalysts, com-
putational protein design and experimentally directed evolution
complement each other well. Use of the design methods pre-
sented here to generate proteins with novel catalytic activity and
directed evolution to further enhance this activity is a promising
path to the production of novel high efficiency protein catalysts.
The relationship between protein fold and function is a
fundamental question in enzymology. From numerous structural
studies, insight has been gained into the properties of the 
barrel fold that have facilitated its evolution to catalyze many
different chemical reactions (42). With the methods presented
here, we may now address the evolvability of essentially any fold
through the computational design of novel enzymatic function
followed by directed evolution. The comparison of an Ab fold to
an  barrel fold, for example, may prove particularly insightful.
Studies of this type may advance our understanding of the
functional potential of protein folds, provide insight into natural
evolution, and aid in the selection of scaffolds for future design
efforts.
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